Tag: Aurobindo Pharma
PAG acquires a majority stake in Pravesha Industries
In a press release datelined Mumbai 13 January 2025, PAG, an Asia Pacific-focused private equity investment firm, announced its acquisition of a majority stake...
CuraTeQ Biologics’ successful phase 1 trial of BP11
CuraTeQ Biologics, a subsidiary of Aurobindo Pharma, announced that their Omalizumab biosimilar candidate BP11 has met the Phase 1 trial endpoints vis-à-vis the EU...
InnoPack Pharma Confex – professionals meet in Mumbai
InnoPack Pharma Conference is a big platform for all the pharmaceutical professionals to meet and exchange ideas and knowledge for the future progress of...
Aurobindo Pharma enlisted PEs stake sale in injectable divisions
PV Ramprasad Reddy, K Nityananda Reddy, and a small group of dedicated experts founded the Aurobindo Pharma in 1986. The firm began operations in...
Molnupiravir newest antiviral for Covid-19
Molnupiravir, the newest antiviral on the market to treat Covid-19, had been submitted to the Indian drug regulatory authorities for approval. Thirteen were given...
Merck’s Molnupiravir tests positive for Covid-19 treatment in India
Pharmaceutical giant Merck recently reported positive results on clinical trials for its antiviral medication Molnupiravir against the novel Coronavirus. According to the clinical trial...
New Mountain Capital to acquire Natrol from Aurobindo Pharma
New York-based investment firm New Mountain Capital announced that it has reached a definitive agreement with Aurobindo Pharma to acquire Natrol and combine it...
Novartis Sandoz terminates sale agreement with Aurobindo
Novartis announced the mutual agreement with Aurobindo Pharma USA to terminate the agreement to sell the Sandoz US generic oral solids and dermatology businesses...